Viewing Study NCT05490095


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-30 @ 6:55 PM
Study NCT ID: NCT05490095
Status: COMPLETED
Last Update Posted: 2022-08-05
First Post: 2022-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults
Sponsor: SoVarGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module